ACT Advisors’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53.1K | Buy |
25,655
+74
| +0.3% | +$153 | 0.02% | 56 |
|
|
2025
Q1 | $56.3K | Hold |
25,581
| – | – | 0.03% | 53 |
|
|
2024
Q4 | $39.1K | Hold |
25,581
| – | – | 0.02% | 49 |
|
|
2024
Q3 | $50.9K | Buy |
25,581
+3,436
| +16% | +$6.84K | 0.02% | 50 |
|
|
2024
Q2 | $77.5K | Hold |
22,145
| – | – | 0.04% | 44 |
|
|
2024
Q1 | $61.3K | Hold |
22,145
| – | – | 0.03% | 43 |
|
|
2023
Q4 | $37.6K | Buy |
+22,145
| New | +$37.6K | 0.02% | 42 |
|